Suppressive Effects of Rosa Damascena Essential Oil on Naloxone-Precipitated Morphine Withdrawal Signs in Male Mice

被引:0
|
作者
Maleki, Navid Abbasi [1 ]
Maleki, Saeid Abbasi [1 ]
Bekhradi, Reza [2 ]
机构
[1] Islamic Azad Univ, Urmia Branch, Dept Pharmacol, Orumiyeh, Iran
[2] Barij Essence Pharmaceut CO, Res Dev & Training Ctr, Kashan, Iran
来源
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH | 2013年 / 12卷 / 03期
关键词
Rosa damascena; Essential oil; Morphine withdrawal; GABAergic system; Mice; RECEPTOR AGONIST; LOCUS-COERULEUS; EXPRESSION;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This research was done to test the effect of Rosa damascena essential oil on withdrawal signs of naloxone-precipitated morphine in male mice. Morphine dependence was induced by injection (IP) three times daily at doses of 50, 50 and 75 mg/kg, respectively, for 3 days. On day 4, after the last administration of morphine, Rosa damascena essential oil was administered at different concentrations (5, 2 and 40%, IP) 30 min before administration of naloxone (5 mg/kg, IP). The following actions were taken as signs of withdrawal and records taken for jumping as a number and scores of 0 to 3 were given for incidences of grooming, teeth chattering, rearing, writing, diarrhea, wet dog shakes and climbing during a 30 min period. Results showed that different concentrations of Rosa damascena essential oil significantly reduced signs of morphine withdrawal compared to the control group in terms of number of jumps (p < 0.05 and p < 0.01), grooming, teeth chattering, rearing, climbing, wet dog shakes and writhing, but not for diarrhea (p < 0.05). In conclusion it seems that GABAergic activity induced by flavonoids from Rosa damascena essential oil can alleviate signs of morphine withdrawal, but further studies need to be done to better understand this mechanism.
引用
收藏
页码:357 / 361
页数:5
相关论文
共 50 条
  • [1] ANANDAMIDE DECREASES NALOXONE-PRECIPITATED WITHDRAWAL SIGNS IN MICE CHRONICALLY TREATED WITH MORPHINE
    VELA, G
    RUIZGAYO, M
    FUENTES, JA
    NEUROPHARMACOLOGY, 1995, 34 (06) : 665 - 668
  • [2] EFFECTS OF IBOGAINE ON NALOXONE-PRECIPITATED WITHDRAWAL IN MORPHINE-DEPENDENT MICE
    FRANCES, B
    GOUT, R
    CROS, J
    ZAJAC, JM
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1992, 6 (8-9) : 327 - 332
  • [3] Suppressive effects of dichloromethane fraction from the Areca catechu nut on naloxone-precipitated morphine withdrawal in mice
    Kumarnsit, E
    Keawpradub, N
    Vongvatcharanon, U
    Sawangjaroen, K
    Govitrapong, P
    FITOTERAPIA, 2005, 76 (06) : 534 - 539
  • [4] Suppressive effects by cysteine protease inhibitors on naloxone-precipitated withdrawal jumping in morphine-dependent mice
    Tan-No, Koichi
    Sato, Tasuku
    Shimoda, Masakazu
    Nakagawasai, Osamu
    Niijima, Fukie
    Kawamura, Shunsuke
    Furuta, Seiichi
    Sato, Takumi
    Satoh, Susumu
    Silberring, Jerzy
    Terenius, Lars
    Tadano, Takeshi
    NEUROPEPTIDES, 2010, 44 (03) : 279 - 283
  • [5] Pharmacokinetic aspects of naloxone-precipitated morphine withdrawal in male and female prepubertal mice
    Diaz, Silvina L.
    Hermida, Maria P.
    Joannas, Leonel D.
    Olivera, Monica
    Ridolfi, Adriana
    Villaamil, Edda C.
    Balerio, Graciela N.
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2007, 28 (06) : 283 - 289
  • [6] Neurosteroids and the naloxone-precipitated withdrawal syndrome in morphine-dependent mice
    Budziszewska, B
    JaworskaFeil, L
    Lason, W
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1996, 6 (02) : 135 - 140
  • [7] NALOXONE-PRECIPITATED WITHDRAWAL AS A FUNCTION OF MORPHINE-NALOXONE INTERVAL
    LINSEMAN, MA
    PSYCHOPHARMACOLOGY, 1977, 54 (02) : 159 - 164
  • [9] ENIGMATIC ACTION OF CYCLOSPORIN-A ON THE NALOXONE-PRECIPITATED MORPHINE WITHDRAWAL SYNDROME IN MICE
    BERTHOLD, H
    BOREL, JF
    FLUCKIGER, E
    NEUROSCIENCE, 1989, 31 (01) : 97 - 103
  • [10] Effect of five common anticonvulsant drugs on naloxone-precipitated morphine withdrawal in mice
    Hajhashemi, V.
    Abed-Natanzi, M.
    RESEARCH IN PHARMACEUTICAL SCIENCES, 2011, 6 (01) : 57 - 62